Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SC 13G/A LUXFER HOLDINGS PLC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A UroGen Pharma Ltd. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A SILICOM LTD. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A CARDTRONICS PLC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Zealand Pharma A/S Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A TOWER SEMICONDUCTOR LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G SINOPEC SHANGHAI PETROCH Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Medtronic plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ICON PLC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Athene Holding Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A BRP Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Third Point Reinsurance Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ASSURED GUARANTY LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A James River Group Holdin Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A METHANEX CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Genpact LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Triton International Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A WHITE MOUNTAINS INSURANC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Enstar Group LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Huazhu Group Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ContextLogic Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Tencent Music Entertainm Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Ascendis Pharma A/S Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MARVELL TECHNOLOGY GROUP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Tarena International, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Payoneer to Become Publicly Traded Company Through Combination With FTAC Olympus Acquisition Corporation (FTOCU) (FTOC)
-
Payoneer to Become Publicly Traded Company Through Combination With FTAC Olympus Acquisition Corporation
-
Form SC 13G Gritstone Oncology, Inc. Filed by: Wellington Management Portfolios (Dublin) Public Ltd Co
-
Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders
-
Latch to Merge with Tishman Speyer-Sponsored SPAC (TSIAU) (TSIA) and Become Publicly Listed Company
-
Latch, Maker of Full-Building Enterprise SaaS Platform LatchOS, to Merge with Tishman Speyer-Sponsored SPAC and Become Publicly Listed Company
-
CI Global Asset Management Funds and ETFs Recognized for Performance by FundGrade® A+ Awards
-
EVgo to Publicly List through Business Combination with Climate Change Crisis Real Impact I Acquisition Corporation (CLII)
-
EVgo, an LS Power Company, and Leader in U.S. Electric Vehicle Fast Charging, to Publicly List through Business Combination with Climate Change Crisis Real Impact I Acquisition Corporation
-
PPRO Raises $180 Million for the Next Era of Local Payments Infrastructure, Is Now Valued Over $1 Billion
-
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
-
Statement of the Ad Hoc Bondholder Group of the Province of Cordoba in Support of Amended Consent Solicitation
-
Verve Therapeutics Announces Data Demonstrating Durable LDL Cholesterol Lowering After a One-Time Gene Editing Treatment in Non-Human Primates
-
Form SC 13G/A Mimecast Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G ESSENTIAL PROPERTIES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Freeline Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G TCR2 THERAPEUTICS INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Aligos Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ARENA PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A PhaseBio Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A SVMK Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A NanoString Technologies Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A bluebird bio, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A OMNICELL, Inc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Affinivax Announces $226 Million Series C Financing to Advance Its Pipeline of Novel MAPS™ Vaccines Targeting Infectious Diseases

